SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-046858
Filing Date
2014-08-05
Accepted
2014-08-04 17:45:43
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v384490_10q.htm 10-Q 316490
2 EXHIBIT 31.1 v384490_ex31-1.htm EX-31.1 11430
3 EXHIBIT 31.2 v384490_ex31-2.htm EX-31.2 11188
4 EXHIBIT 32.1 v384490_ex32-1.htm EX-32.1 5345
5 EXHIBIT 32.2 v384490_ex32-2.htm EX-32.2 5418
  Complete submission text file 0001144204-14-046858.txt   3179952

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pip-20140630.xml EX-101.INS 336240
7 XBRL TAXONOMY EXTENSION SCHEMA pip-20140630.xsd EX-101.SCH 37052
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pip-20140630_cal.xml EX-101.CAL 41806
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pip-20140630_def.xml EX-101.DEF 120577
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pip-20140630_lab.xml EX-101.LAB 519033
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pip-20140630_pre.xml EX-101.PRE 212969
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 141014092
SIC: 2834 Pharmaceutical Preparations